Todd Brady, MD, PhD, from Apprentice to CEO


Podcast Episode 246

Click here to watch the video version of this podcast.


No, not that apprentice. Todd Brady, MD, PhD, turned VC/EIR (for venture capitalist, entrepreneur in residence), turned CEO of Aldeyra Therapeutics back in 2012, talks about how he transitioned from the lab to the “dark side” back in the 1990s when “industry” was still a dirty word. Todd found his calling as a company builder who has since taken Aldeyra public and into Phase III trials with novel treatments for dry eye disease, allergic conjunctivitis, and proliferative vitreoretinopathy. The company is also developing other product candidates for retinal and systemic inflammatory diseases. Listen in for some words of wisdom from the real “Apprentice.”

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Meet Our Hosts

Ehsan Sadri
ehsan sadri
Firas Rahhal
FirasRahhal
Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.